Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland.
about
Chronic hepatitis C: This and the new era of treatmentClinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis CRelevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patientsAssessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections.Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antiviralsTreatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies.Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.Clinical outcomes in a cohort of anti-hepatitis C virus-positive patients with significant barriers to treatment referred to a Norwegian outpatient clinic.Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness.
P2860
Q26775011-1758CFC7-CD6C-4A12-896D-A8DD39C5122FQ28080225-2C6A59B7-0930-4505-A3B8-82CDAB529CD6Q34981566-BC0927F6-78CF-4712-8FAE-52C543030C4EQ35565944-A90F2A42-97C3-499C-B841-D350C2B4E16FQ37601315-AAAC3BAA-7DE0-4C61-997E-CF9B8E66C9F0Q38123948-7B3E6FDA-701D-4FA7-8ECF-2916712FB574Q38800572-0CB8920D-7881-466D-A5B9-6BE71C5A6B30Q41672541-C7613380-F1E1-4FA7-9C0D-9ABC9726D5FFQ42159672-2386817A-CDD3-4484-A114-77B736BFB0EDQ42240532-B789C7AA-53A3-482F-94C7-427D19C8337EQ45354911-5774509A-3001-425A-8162-8050AACE0E7A
P2860
Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ranking predictors of a sustai ...... ron and ribavirin in Scotland.
@en
Ranking predictors of a sustai ...... ron and ribavirin in Scotland.
@nl
type
label
Ranking predictors of a sustai ...... ron and ribavirin in Scotland.
@en
Ranking predictors of a sustai ...... ron and ribavirin in Scotland.
@nl
prefLabel
Ranking predictors of a sustai ...... ron and ribavirin in Scotland.
@en
Ranking predictors of a sustai ...... ron and ribavirin in Scotland.
@nl
P2093
P50
P1476
Ranking predictors of a sustai ...... ron and ribavirin in Scotland.
@en
P2093
Bill Carman
Chris Robertson
David J Goldberg
Diptendu Bhattacharyya
Hamish A Innes
Hepatitis C Clinical Database Monitoring Committee
John Morris
Judith Morris
Peter Bramley
Peter Hayes
P304
P356
10.1097/MEG.0B013E32835201A4
P577
2012-06-01T00:00:00Z